EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
31 hedge funds and large institutions have $47.8M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+10
Holders Change %
+47.62%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACM
Altium Capital Management
New York
|
+$3.94M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.97M |
| 3 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$1.65M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.19M |
| 5 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
+$985K |
Top Sellers
| 1 |
SC
Shay Capital
New York
|
-$3.7M |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$985K |
| 3 |
CAC
Cowen and Company
New York
|
-$652K |
| 4 |
CC
Centiva Capital
New York
|
-$3.94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.51K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Goldman Sachs
New York
| $109K | +$109K | +11,099 | New |
|
|
EAM
27
Exos Asset Management
New York
| $103K | – | – | – |
|
|
PAM
28
Panagora Asset Management
Boston,
Massachusetts
| $98K | +$98K | +9,922 | New |
|
29
Morgan Stanley
New York
| $38K | +$38K | +3,900 | New |
|
|
30
UBS Group
Zurich,
Switzerland
| $37K | -$1.51K | -155 | -4% |
|
|
MF
31
Magnetar Financial
Evanston,
Illinois
| $116 | +$116 | +11,800 | New |
|
|
CAC
32
Cowen and Company
New York
| – | -$652K | -65,296 | Closed |
|